Eden vs Henry Meds (2026): prices, structure, verdict

On tirzepatide, Henry Meds↗ is cheaper: $349 versus $408 a month all-in — a $59 monthly gap, $708 across a year of maintenance dosing, and Henry Meds's figure is dose-flat while Eden's structure is not.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Henry Meds is cheaper: $179 versus $198 a month all-in — a $19 monthly gap, $228 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Eden: the record, condensed

Eden’s tirzepatide program bills $408 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Note the shape: $348 is the number in the marketing, $408 is the number at maintenance. The $60 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

A required $99/month membership is part of the deal, and part of the figure above: $309 of medication plus $99 of platform equals the $408 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #16 of 17 verified programs, with the floor $193/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $41 a month. A year at this figure: $4,896 monthly-billed.

On semaglutide, the number that matters at Eden is $198 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Eden is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

A required $99/month membership is part of the deal, and part of the figure above: $99 of medication plus $99 of platform equals the $198 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #10 of 20 in the verified semaglutide index — $65/month above the floor (Oak Longevity, $133) — and sits $151 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,376.

Operationally at Eden: shipping included; commitment membership auto-renews; cancellation membership auto-renews until cancelled; pharmacy not publicly named — ask in writing before paying; states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Eden page · visit Eden ↗

Henry Meds: the record, condensed

Start with the load-bearing figure: $349 a month, all-in, is what Henry Meds charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Henry Meds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #10 of 17 verified programs, with the floor $134/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $100 a month. A year at this figure: $4,188 monthly-billed.

On semaglutide, the number that matters at Henry Meds is $179 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $179 is the whole subscription, which makes Henry Meds unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #9 of 20 in the verified semaglutide index — $46/month above the floor (Oak Longevity, $133) — and sits $170 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,148.

Operationally at Henry Meds: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Henry Meds page · visit Henry Meds ↗

Tirzepatide: the duel in full

Put the two tirzepatide figures side by side and hold them there: Henry Meds at $349, Eden at $408 — a $59 monthly spread that compounds to $708 over a maintenance year and $1,416 over two.

Structure sharpens the gap: Henry Meds’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while Eden’s is not — so Henry Meds’s number is a ceiling and Eden’s advertised entry ($348) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

Eden’s total includes a mandatory $99/month membership; Henry Meds has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $179 (Henry Meds) against $198 (Eden). $19 a month sounds survivable; $228 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $19 gap is exactly what it appears to be.

Eden’s total includes a mandatory $99/month membership; Henry Meds has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

A way to feel the $59 monthly gap: over a year it funds 2.0 extra months at Henry Meds’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $1,416, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Eden $408/mo month-to-month against Henry Meds $349/mo month-to-month. The order holds: Henry Meds leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Eden $1,224 monthly; Henry Meds $1,047 monthly — best path favors Henry Meds by $177. 6 months: Eden $2,448 monthly; Henry Meds $2,094 monthly — best path favors Henry Meds by $354. 12 months: Eden $4,896 monthly; Henry Meds $4,188 monthly — best path favors Henry Meds by $708. 24 months: Eden $9,792 monthly; Henry Meds $8,376 monthly — best path favors Henry Meds by $1,416.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: Eden $594 vs Henry Meds $537 — $57 to Henry Meds. 6 mo: Eden $1,188 vs Henry Meds $1,074 — $114 to Henry Meds. 12 mo: Eden $2,376 vs Henry Meds $2,148 — $228 to Henry Meds. 24 mo: Eden $4,752 vs Henry Meds $4,296 — $456 to Henry Meds.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: Eden publishes “most states”; Henry Meds publishes “most states” — for anything short of an explicit 50-state claim, intake is the final word.

Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.

Exit terms: Eden — membership auto-renews; membership auto-renews until cancelled. Henry Meds — none month-to-month; check terms before prepaying.

Evidence: Eden source-verified (captured 2026-08-05); Henry Meds third-party reported (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full tirzepatide index these two sit at #16 and #10 of 17: between them lie 5 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #10 and #9 of 20: between them lie 0 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Eden and Henry Meds

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Eden: membership auto-renews until cancelled; Henry Meds: check terms before prepaying) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings